B. MESCI Et Al. , "TRIPLE ORAL ANTIDIABETIC OR METFORMIN-BASAL INSULIN COMBINATION: TESTING TWO DIFFERENT APPROACHES OF CONSENSUS ALGORITHM IN ADJUSTING ANTIDIABETIC THERAPY. AN OPEN-LABEL, RANDOMIZED STUDY," ACTA ENDOCRINOLOGICA-BUCHAREST , vol.8, no.4, pp.587-594, 2012
MESCI, B. Et Al. 2012. TRIPLE ORAL ANTIDIABETIC OR METFORMIN-BASAL INSULIN COMBINATION: TESTING TWO DIFFERENT APPROACHES OF CONSENSUS ALGORITHM IN ADJUSTING ANTIDIABETIC THERAPY. AN OPEN-LABEL, RANDOMIZED STUDY. ACTA ENDOCRINOLOGICA-BUCHAREST , vol.8, no.4 , 587-594.
MESCI, B., OGUZ, A., KILIC, D. C., CELIK, S., SAHIN, G., Tekin, M., ... SARIISIK, A.(2012). TRIPLE ORAL ANTIDIABETIC OR METFORMIN-BASAL INSULIN COMBINATION: TESTING TWO DIFFERENT APPROACHES OF CONSENSUS ALGORITHM IN ADJUSTING ANTIDIABETIC THERAPY. AN OPEN-LABEL, RANDOMIZED STUDY. ACTA ENDOCRINOLOGICA-BUCHAREST , vol.8, no.4, 587-594.
MESCI, B. Et Al. "TRIPLE ORAL ANTIDIABETIC OR METFORMIN-BASAL INSULIN COMBINATION: TESTING TWO DIFFERENT APPROACHES OF CONSENSUS ALGORITHM IN ADJUSTING ANTIDIABETIC THERAPY. AN OPEN-LABEL, RANDOMIZED STUDY," ACTA ENDOCRINOLOGICA-BUCHAREST , vol.8, no.4, 587-594, 2012
MESCI, B. Et Al. "TRIPLE ORAL ANTIDIABETIC OR METFORMIN-BASAL INSULIN COMBINATION: TESTING TWO DIFFERENT APPROACHES OF CONSENSUS ALGORITHM IN ADJUSTING ANTIDIABETIC THERAPY. AN OPEN-LABEL, RANDOMIZED STUDY." ACTA ENDOCRINOLOGICA-BUCHAREST , vol.8, no.4, pp.587-594, 2012
MESCI, B. Et Al. (2012) . "TRIPLE ORAL ANTIDIABETIC OR METFORMIN-BASAL INSULIN COMBINATION: TESTING TWO DIFFERENT APPROACHES OF CONSENSUS ALGORITHM IN ADJUSTING ANTIDIABETIC THERAPY. AN OPEN-LABEL, RANDOMIZED STUDY." ACTA ENDOCRINOLOGICA-BUCHAREST , vol.8, no.4, pp.587-594.
@article{article, author={B. MESCI Et Al. }, title={TRIPLE ORAL ANTIDIABETIC OR METFORMIN-BASAL INSULIN COMBINATION: TESTING TWO DIFFERENT APPROACHES OF CONSENSUS ALGORITHM IN ADJUSTING ANTIDIABETIC THERAPY. AN OPEN-LABEL, RANDOMIZED STUDY}, journal={ACTA ENDOCRINOLOGICA-BUCHAREST}, year=2012, pages={587-594} }